Vericel Quarterly Cash Flow Statement
NASDAQ: VCELHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Vericel free cash flow
In the quarter ended Jun 30, 2026, Vericel generated $16.2 million of operating cash flow and spent $1.9 million on capital expenditures. That left free cash flow of $14.3 million, a free-cash-flow margin of 18.4% of revenue. Free cash flow was up 17503.7% from the prior year's $81,000.
Summary generated from market data by MetaCap's automated system. Methodology
Vericel cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 2.21M | -6.30M | 23.24M | 5.07M | -553.00K | -11.25M | 19.81M | -901.00K | -4.68M | -3.86M | 12.99M | -3.66M |
| Net Income growth (YoY) | — | — | +17.35% | — | — | — | +52.44% | — | — | — | +119.40% | — |
| Depreciation & Amortization | 3.62M | 3.27M | 3.09M | 2.94M | 2.83M | 2.69M | 1.48M | 1.33M | 1.32M | 1.38M | 1.15M | 1.15M |
| Stock-Based Compensation | 9.08M | 11.29M | 8.42M | 8.70M | 10.14M | 11.51M | 7.92M | 9.22M | 9.52M | 9.83M | 6.91M | 7.92M |
| Change in Working Capital | -1.88M | 13.88M | -23.70M | 5.37M | -11.29M | 9.17M | -13.10M | -2.74M | 5.33M | 3.12M | -16.37M | -707.00K |
| Operating Cash Flow | 16.19M | 16.38M | 15.01M | 22.08M | 8.21M | 6.60M | 22.24M | 10.18M | 18.54M | 7.20M | 10.09M | 7.17M |
| Capital Expenditures | -1.93M | -1.26M | -2.19M | -2.63M | -8.13M | -14.21M | -13.79M | -19.41M | -16.76M | -14.02M | -7.83M | -6.57M |
| Investing Cash Flow | -2.82M | -4.20M | -16.39M | -3.38M | -9.03M | -15.14M | -14.65M | -21.21M | -17.72M | -25.45M | -8.09M | 4.57M |
| Financing Cash Flow | 2.69M | -2.98M | 1.06M | 1.17M | 1.64M | 3.20M | 7.11M | 5.52M | 4.30M | 2.13M | 1.31M | 1.01M |
| Net Change in Cash | 16.06M | 9.20M | -311.00K | 19.87M | 827.00K | -5.34M | 14.70M | -5.50M | 5.11M | -16.12M | 3.31M | 12.74M |
| Free Cash Flow | 14.26M | 15.13M | 12.83M | 19.45M | 81.00K | -7.61M | 8.46M | -9.22M | 1.77M | -6.82M | 2.25M | 600.00K |
This table shows 12 quarterly periods of Vericel's cash flow statement, from Q2 2026 back to Q3 2023, across 11 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow VCEL's reporting calendar. What is a cash flow statement?